These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
217 related articles for article (PubMed ID: 12787571)
1. Viruses and the TNF-related cytokines, an evolving battle. Benedict CA Cytokine Growth Factor Rev; 2003; 14(3-4):349-57. PubMed ID: 12787571 [TBL] [Abstract][Full Text] [Related]
2. Was exposure to directly antiviral cytokines during primary infection an important selective pressure in the evolution of unique immune evasion strategies by viruses? Lidbury BA Immunol Cell Biol; 1994 Aug; 72(4):347-50. PubMed ID: 7528723 [TBL] [Abstract][Full Text] [Related]
3. To kill or be killed: viral evasion of apoptosis. Benedict CA; Norris PS; Ware CF Nat Immunol; 2002 Nov; 3(11):1013-8. PubMed ID: 12407409 [TBL] [Abstract][Full Text] [Related]
4. Apo2L/TRAIL: apoptosis signaling, biology, and potential for cancer therapy. Almasan A; Ashkenazi A Cytokine Growth Factor Rev; 2003; 14(3-4):337-48. PubMed ID: 12787570 [TBL] [Abstract][Full Text] [Related]
5. Host defense, viruses and apoptosis. Barber GN Cell Death Differ; 2001 Feb; 8(2):113-26. PubMed ID: 11313713 [TBL] [Abstract][Full Text] [Related]
6. Apoptosis control by death and decoy receptors. Ashkenazi A; Dixit VM Curr Opin Cell Biol; 1999 Apr; 11(2):255-60. PubMed ID: 10209153 [TBL] [Abstract][Full Text] [Related]
8. Noncytolytic control of viral infections by the innate and adaptive immune response. Guidotti LG; Chisari FV Annu Rev Immunol; 2001; 19():65-91. PubMed ID: 11244031 [TBL] [Abstract][Full Text] [Related]
11. [Current concepts on apoptotic signalling pathways: new targets for anticancer strategies]. Ségal-Bendirdjian E; Hillion J; Belmokhtar CA Bull Cancer; 2003 Jan; 90(1):9-17. PubMed ID: 12609799 [TBL] [Abstract][Full Text] [Related]
12. TNF and TNF receptor superfamily members in HIV infection: new cellular targets for therapy? Kumar A; Abbas W; Herbein G Mediators Inflamm; 2013; 2013():484378. PubMed ID: 24453421 [TBL] [Abstract][Full Text] [Related]
13. Interferons and apoptosis. Clemens MJ J Interferon Cytokine Res; 2003 Jun; 23(6):277-92. PubMed ID: 12859854 [TBL] [Abstract][Full Text] [Related]
14. TRAIL/Apo-2L: mechanisms and clinical applications in cancer. Srivastava RK Neoplasia; 2001; 3(6):535-46. PubMed ID: 11774036 [TBL] [Abstract][Full Text] [Related]
15. Intracellular mechanisms of TRAIL: apoptosis through mitochondrial-dependent and -independent pathways. Suliman A; Lam A; Datta R; Srivastava RK Oncogene; 2001 Apr; 20(17):2122-33. PubMed ID: 11360196 [TBL] [Abstract][Full Text] [Related]
16. Messengers of cell death: apoptotic signaling in health and disease. Rossi D; Gaidano G Haematologica; 2003 Feb; 88(2):212-8. PubMed ID: 12604411 [TBL] [Abstract][Full Text] [Related]
17. The signaling adaptors and pathways activated by TNF superfamily. Dempsey PW; Doyle SE; He JQ; Cheng G Cytokine Growth Factor Rev; 2003; 14(3-4):193-209. PubMed ID: 12787559 [TBL] [Abstract][Full Text] [Related]
18. Mechanisms of action of the tumor necrosis factor and lymphotoxin ligand-receptor system. Warzocha K; Bienvenu J; Coiffier B; Salles G Eur Cytokine Netw; 1995; 6(2):83-96. PubMed ID: 7578992 [TBL] [Abstract][Full Text] [Related]
19. TWEAK, a member of the TNF superfamily, is a multifunctional cytokine that binds the TweakR/Fn14 receptor. Wiley SR; Winkles JA Cytokine Growth Factor Rev; 2003; 14(3-4):241-9. PubMed ID: 12787562 [TBL] [Abstract][Full Text] [Related]
20. The complexity of TNF-related apoptosis-inducing ligand. Abe K; Kurakin A; Mohseni-Maybodi M; Kay B; Khosravi-Far R Ann N Y Acad Sci; 2000; 926():52-63. PubMed ID: 11193041 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]